Pannónia Magánorvosi Centrum

Budapest 1136

1 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling